Please wait while the formulary information is being retrieved.
FELBAMATE (felbamate)
- Complex-partial epilepsy
- Lennox-gastaut epilepsy
- Partial epilepsy treatment adjunct
- Simple-partial epilepsy
400 mg tablet
- 1 tablet (400 mg) by oral route 3 times per day
600 mg tablet
- 1 tablet (600 mg) by oral route 3 times per day
600 mg/5 mL oral suspension
- 5 milliliters (600 mg) by oral route 4 times per day
400 mg tablet
- 1 tablet (400 mg) by oral route 3 times per day
600 mg tablet
- 1 tablet (600 mg) by oral route 3 times per day
600 mg/5 mL oral suspension
- 5 milliliters (600 mg) by oral route 4 times per day
Complex-partial epilepsy
- 2 tablets (1,200 mg) by oral route 3 times per day
- 10 milliliters (1,200 mg) by oral route 3 times per day
- one-half tablet (300 mg) by oral route 4 times per day
- 2.5 milliliters (300 mg) by oral route 4 times per day
- 3.3 milliliters (400 mg) by oral route 3 times per day
- 1 tablet (400 mg) by oral route 3 times per day
- 3.75 milliliters (450 mg) by oral route 4 times per day
- 5 milliliters (600 mg) by oral route 3 times per day
- 1 tablet (600 mg) by oral route 3 times per day
- 1 tablet (600 mg) by oral route 4 times per day
- 5 milliliters (600 mg) by oral route 4 times per day
- 2 tablets (800 mg) by oral route 3 times per day
- 6.7 milliliters (800 mg) by oral route 3 times per day
- 7.5 milliliters (900 mg) by oral route 4 times per day
- 1.5 tablets (900 mg) by oral route 4 times per day
Epilepsy
- 2 tablets (1,200 mg) by oral route 3 times per day
- 10 milliliters (1,200 mg) by oral route 3 times per day
- one-half tablet (300 mg) by oral route 4 times per day
- 2.5 milliliters (300 mg) by oral route 4 times per day
- 3.3 milliliters (400 mg) by oral route 3 times per day
- 1 tablet (400 mg) by oral route 3 times per day
- 3.75 milliliters (450 mg) by oral route 4 times per day
- 5 milliliters (600 mg) by oral route 3 times per day
- 1 tablet (600 mg) by oral route 3 times per day
- 1 tablet (600 mg) by oral route 4 times per day
- 5 milliliters (600 mg) by oral route 4 times per day
- 2 tablets (800 mg) by oral route 3 times per day
- 6.7 milliliters (800 mg) by oral route 3 times per day
- 7.5 milliliters (900 mg) by oral route 4 times per day
- 1.5 tablets (900 mg) by oral route 4 times per day
Partial epilepsy treatment adjunct
- 2 tablets (1,200 mg) by oral route 3 times per day
- 10 milliliters (1,200 mg) by oral route 3 times per day
- one-half tablet (300 mg) by oral route 4 times per day
- 2.5 milliliters (300 mg) by oral route 4 times per day
- 3.3 milliliters (400 mg) by oral route 3 times per day
- 1 tablet (400 mg) by oral route 3 times per day
- 3.75 milliliters (450 mg) by oral route 4 times per day
- 5 milliliters (600 mg) by oral route 3 times per day
- 1 tablet (600 mg) by oral route 3 times per day
- 1 tablet (600 mg) by oral route 4 times per day
- 5 milliliters (600 mg) by oral route 4 times per day
- 2 tablets (800 mg) by oral route 3 times per day
- 6.7 milliliters (800 mg) by oral route 3 times per day
- 7.5 milliliters (900 mg) by oral route 4 times per day
- 1.5 tablets (900 mg) by oral route 4 times per day
Simple-partial epilepsy
- 2 tablets (1,200 mg) by oral route 3 times per day
- 10 milliliters (1,200 mg) by oral route 3 times per day
- one-half tablet (300 mg) by oral route 4 times per day
- 2.5 milliliters (300 mg) by oral route 4 times per day
- 3.3 milliliters (400 mg) by oral route 3 times per day
- 1 tablet (400 mg) by oral route 3 times per day
- 3.75 milliliters (450 mg) by oral route 4 times per day
- 5 milliliters (600 mg) by oral route 3 times per day
- 1 tablet (600 mg) by oral route 3 times per day
- 1 tablet (600 mg) by oral route 4 times per day
- 5 milliliters (600 mg) by oral route 4 times per day
- 2 tablets (800 mg) by oral route 3 times per day
- 6.7 milliliters (800 mg) by oral route 3 times per day
- 7.5 milliliters (900 mg) by oral route 4 times per day
- 1.5 tablets (900 mg) by oral route 4 times per day
- None
Contraindicated
- Altavera (28)
- Alyacen 1/35 (28)
- Alyacen 7/7/7 (28)
- Amethia
- Amethia Lo
- Amethyst
- amiodarone
- amiodarone in dextrose,iso-osm
- Apri
- Aranelle (28)
- artemether-lumefantrine
- Aubra
- Aviane
- Azurette (28)
- Balziva (28)
- Beyaz
- Brevicon (28)
- Briellyn
- Camila
- Camrese
- Camrese Lo
- Caziant (28)
- Chateal
- citalopram
- clopidogrel
- Coartem
- Cordarone
- Cryselle (28)
- Cyclafem 1/35 (28)
- Cyclafem 7/7/7 (28)
- Cyclessa (28)
- Dasetta 1/35 (28)
- Dasetta 7/7/7 (28)
- Daysee
- desog-e.estradiol/e.estradiol
- Desogen
- desogestrel-ethinyl estradiol
- disopyramide
- dronedarone
- droperidol
- drospirenone-e.estradiol-lm.FA
- drospirenone-ethinyl estradiol
- Elinest
- Emoquette
- Enpresse
- Enskyce
- Errin
- Estarylla
- estradiol valerate-dienogest
- Estrostep Fe-28
- ethynodiol diac-eth estradiol
- etonogestrel
- etonogestrel-ethinyl estradiol
- Falmina (28)
- Femcon Fe
- Generess Fe
- Geodon
- Gianvi (28)
- Gildagia
- Gildess
- Gildess Fe
- Heather
- Introvale
- Jencycla
- Jolessa
- Jolivette
- Junel 1.5/30 (21)
- Junel 1/20 (21)
- Junel Fe 1.5/30 (28)
- Junel Fe 1/20 (28)
- Kariva (28)
- Kelnor 1/35 (28)
- Kurvelo
- L norgest&E estradiol-E estrad
- Larin 1/20 (21)
- Larin Fe
- Leena 28
- Lessina
- Levonest (28)
- levonorg-eth estrad triphasic
- levonorgestrel
- levonorgestrel-ethinyl estrad
- Levora 0.15/30 (28)
- Levora-28
- Lo Loestrin Fe
- Loestrin 1.5/30 (21)
- Loestrin 1/20 (21)
- Loestrin Fe 1.5/30 (28)
- Loestrin Fe 1/20 (28)
- Lomedia 24 Fe
- Loryna (28)
- Loseasonique
- Low-ogestrel (28)
- Lutera (28)
- Lyza
- Marlissa
- Microgestin 1.5/30 (21)
- Microgestin 1/20 (21)
- Microgestin Fe 1.5/30 (28)
- Microgestin Fe 1/20 (28)
- Minastrin 24 Fe
- Mircette (28)
- Mirena
- Modicon (28)
- Mono-linyah
- Mononessa (28)
- Multaq
- My Way
- Myzilra
- Natazia
- Necon 0.5/35 (28)
- Necon 1/35 (28)
- Necon 1/50 (28)
- Necon 10/11 (28)
- Necon 7/7/7 (28)
- Nexplanon
- Next Choice One Dose
- Nexterone
- Nor-qd
- Nora-be
- norelgestrom-ethinyl estradiol
- noreth-ethinyl estradiol-iron
- norethin-e.estradiol triphasic
- norethin-eth estrad biphasic
- norethindrone (contraceptive)
- norethindrone ac-eth estradiol
- norethindrone-e.estradiol-iron
- norethindrone-ethin estradiol
- norethindrone-mestranol
- norgestimate-ethinyl estradiol
- norgestrel-ethinyl estradiol
- Norinyl 1+35 (28)
- Norinyl 1+50 (28)
- Norpace
- Norpace Cr
- Nortrel 0.5/35 (28)
- Nortrel 1/35 (21)
- Nortrel 1/35 (28)
- Nortrel 7/7/7 (28)
- Nuvaring
- Ocella
- Ogestrel (28)
- Orap
- Orsythia
- Ortho Evra
- Ortho Micronor
- Ortho Tri-cyclen (28)
- Ortho Tri-cyclen Lo (28)
- Ortho-cept (28)
- Ortho-cyclen (28)
- Ortho-novum 1/35 (28)
- Ortho-novum 7/7/7 (28)
- Ovcon-35 (28)
- Pacerone
- Philith
- pimozide
- Pimtrea (28)
- Pirmella
- Plan B One-step
- Plavix
- Portia
- Previfem
- Quartette
- Quasense
- Reclipsen (28)
- Safyral
- Seasonique
- Skyla
- Sprintec (28)
- Sronyx
- Syeda
- thioridazine
- Tilia Fe
- Tri-estarylla
- Tri-legest Fe
- Tri-linyah
- Tri-norinyl (28)
- Tri-previfem (28)
- Tri-sprintec (28)
- Trinessa (28)
- Trivora (28)
- Velivet Triphasic Regimen (28)
- Vestura (28)
- Viorele (28)
- Vyfemla (28)
- Wera (28)
- Wymzya Fe
- Yasmin (28)
- Yaz 28
- Zarah
- Zenchent (28)
- Zenchent Fe
- Zeosa
- ziprasidone HCl
- ziprasidone mesylate
- Zovia 1/35E (28)
- Zovia 1/50E (28)
Severe
Moderate
- Ablavar
- alfuzosin
- Anzemet
- Apokyn
- apomorphine
- arsenic trioxide
- Avelox
- Avelox Abc Pack
- Avelox In Nacl (iso-osmotic)
- bedaquiline
- Betapace
- Betapace Af
- Caprelsa
- carbamazepine
- Carbatrol
- Celexa
- Cipro
- Cipro In D5W
- Cipro Xr
- ciprofloxacin
- ciprofloxacin (mixture)
- ciprofloxacin in D5W
- clozapine
- Clozaril
- Complera
- crizotinib
- dasatinib
- Depacon
- Depakene
- Depakote
- Depakote Er
- Depakote Sprinkles
- Diskets
- divalproex
- dofetilide
- dolasetron
- Dolophine
- Edurant
- emtricitab-rilpivirine-tenofov
- Epitol
- Equetro
- eribulin
- escitalopram oxalate
- ezogabine
- Fareston
- Fazaclo
- gadofosveset trisodium
- Halaven
- Haldol
- Haldol Decanoate
- haloperidol
- haloperidol decanoate
- haloperidol lactate
- Invega
- Invega Sustenna
- Invirase
- Istodax
- Kaletra
- lapatinib
- Levaquin
- Levaquin In 5 % Dextrose
- levofloxacin
- levofloxacin in D5W
- Lexapro
- lopinavir-ritonavir
- methadone
- Methadone Intensol
- Methadose
- moxifloxacin
- moxifloxacin in NaCl (iso-osm)
- Nexavar
- nilotinib
- norfloxacin
- Noroxin
- Noxafil
- ondansetron
- ondansetron HCl
- ondansetron HCl (PF)
- paliperidone
- paliperidone palmitate
- pasireotide
- pazopanib
- posaconazole
- Potiga
- propafenone
- Qualaquin
- quetiapine
- quinine sulfate
- rilpivirine
- romidepsin
- Rythmol
- saquinavir mesylate
- Seroquel
- Seroquel Xr
- Signifor
- Sirturo
- sorafenib
- Sorine
- sotalol
- Sotalol Af
- Sprycel
- Stavzor
- Tasigna
- Tegretol
- Tegretol Xr
- telavancin
- tetrabenazine
- Tikosyn
- toremifene
- Trisenox
- Tykerb
- Uroxatral
- valproate sodium
- valproic acid
- valproic acid (as sodium salt)
- vandetanib
- vemurafenib
- Versacloz
- Vibativ
- Votrient
- Xalkori
- Xenazine
- Zelboraf
- Zofran
- Zofran Odt
- Zuplenz
- Aplastic anemia
- Blood dyscrasias
- Bone marrow depression
- Disease of liver
- Hepatic failure
- Lactating mother
Contraindicated
- Abnormal hepatic function tests
- Congenital long QT syndrome
- Porphyria
- Prolonged QT interval
- Suicidal ideation
- Torsades de pointes
Severe
Moderate
- Depression
- Kidney disease with reduction in GFR
FELBAMATE (felbamate)
- Complex-partial epilepsy
- Lennox-gastaut epilepsy
- Partial epilepsy treatment adjunct
- Simple-partial epilepsy
- Fever
- Gait abnormality
- Purpura
- Abdominal pain with cramps
- Anorexia
- Constipation
- Disorder of the digestive system
- Dizziness
- Dysgeusia
- Dyspepsia
- Headache disorder
- Insomnia
- Nausea
- Vomiting
More Frequent
Severe
Less Severe
- Aggressive behavior
- Agitation
- Altered mental status
- Ataxia
- CNS toxicity
- Mood changes
- Skin rash
- Tremor
- Blurred vision
- Diarrhea
- Diplopia
- Drowsy
- Nervousness
- Rhinitis
- Symptoms of anxiety
- Upper respiratory infection
- Weight loss
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute hepatic failure
- Agranulocytosis
- Anaphylaxis
- Aplastic anemia
- Blood dyscrasias
- Bone marrow depression
- Drug-induced psychosis
- Dyspnea
- Facial edema
- Leukopenia
- Lymphadenopathy
- Nasal congestion
- Neutropenic disorder
- Pancytopenia
- Prolonged QT interval
- Pruritus of skin
- Qualitative platelet disorder
- Skin photosensitivity
- Stevens-johnson syndrome
- Suicidal ideation
- Thrombocytopenic disorder
- Urticaria
Less Severe
- Behavioral disorders
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Felbamate
Approved only as adjunctive therapy for Lennox-Gastaut. Monitor behavior, risk of suicidal ideation and behavior.
- 1 Day – 18 Years
- Approved only as adjunctive therapy for Lennox-Gastaut. Monitor behavior, risk of suicidal ideation and behavior.
Felbamate
- Severity Level:
C
- Additional Notes:
Contraindicated
Felbamate
Potential sev toxicity;Decreased pup wt, increased mortality in rat studies.
| General | Excretion Potential | Effect on Infant | Notes |
| Drug should not be given to breast feeding mothers | Excreted | Not known; no or inclusive data | Potential sev toxicity;Decreased pup wt, increased mortality in rat studies. |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Felbamate
Neuro/Psych-Use caution in elderly with a history of recurrent falls. Drug may produce ataxia, impaired psychomotor function, syncope, and additional falls. Renal-Start with half the normal adult dose with decreased CrCL.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | Y | N | N | Y | N | N |
BEERS: Y HEDIS: Y STOPP: Y
No Known Risk
None
- Severe (sometimes fatal) blood/bone marrow problems (such as low red/white blood cells and platelets) and liver problems have occurred with felbamate. Felbamate should be used only by people with severe seizures (epilepsy) that cannot be controlled with other medications. Do not use this drug if you have liver problems.<br /><br />Discuss the risks and benefits with your doctor before starting felbamate. Tell your doctor right away if you have signs of infection (such as sore throat that doesn't go away, fever, chills), signs of anemia (such as unusual tiredness), easy bruising/bleeding, or signs of liver problems (such as nausea/vomiting that doesn't stop, stomach/abdominal pain, yellowing eyes/skin, dark urine). Usually, people who have liver problems while taking this drug should not start taking it again.<br /><br /> Your doctor will check certain blood tests (liver function, complete blood count) and may have you see a doctor who treats blood/bone marrow problems before you start felbamate and while you use this drug. Blood/bone marrow problems may also occur after you stop taking the drug. Blood tests may be needed for some time after you stop taking felbamate. Keep all medical and lab appointments.
| Complex-partial epilepsy | |
| G40.0 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset |
| G40.00 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable |
| G40.009 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, without status epilepticus |
| G40.01 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable |
| G40.019 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, without status epilepticus |
| G40.2 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures |
| G40.20 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable |
| G40.209 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, without status epilepticus |
| G40.21 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable |
| G40.219 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, without status epilepticus |
| Lennox-gastaut epilepsy | |
| G40.81 | Lennox-gastaut syndrome |
| G40.812 | Lennox-gastaut syndrome, not intractable, without status epilepticus |
| G40.814 | Lennox-gastaut syndrome, intractable, without status epilepticus |
| Partial epilepsy treatment adjunct | |
| G40.0 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset |
| G40.00 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable |
| G40.009 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, without status epilepticus |
| G40.01 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable |
| G40.019 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, without status epilepticus |
| G40.1 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures |
| G40.10 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable |
| G40.109 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus |
| G40.11 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable |
| G40.119 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, without status epilepticus |
| G40.2 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures |
| G40.20 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable |
| G40.209 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, without status epilepticus |
| G40.21 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable |
| G40.219 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, without status epilepticus |
| Simple-partial epilepsy | |
| G40.0 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset |
| G40.00 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable |
| G40.009 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, without status epilepticus |
| G40.01 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable |
| G40.019 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, without status epilepticus |
| G40.1 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures |
| G40.10 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable |
| G40.109 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus |
| G40.11 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable |
| G40.119 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, without status epilepticus |
| 0-9 | A-Z |
|---|---|
| G40.0 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset |
| G40.0 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset |
| G40.0 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset |
| G40.00 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable |
| G40.00 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable |
| G40.00 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable |
| G40.009 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, without status epilepticus |
| G40.009 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, without status epilepticus |
| G40.009 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, without status epilepticus |
| G40.01 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable |
| G40.01 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable |
| G40.01 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable |
| G40.019 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, without status epilepticus |
| G40.019 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, without status epilepticus |
| G40.019 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, without status epilepticus |
| G40.1 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures |
| G40.1 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures |
| G40.10 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable |
| G40.10 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable |
| G40.109 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus |
| G40.109 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus |
| G40.11 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable |
| G40.11 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable |
| G40.119 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, without status epilepticus |
| G40.119 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, without status epilepticus |
| G40.2 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures |
| G40.2 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures |
| G40.20 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable |
| G40.20 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable |
| G40.209 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, without status epilepticus |
| G40.209 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, without status epilepticus |
| G40.21 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable |
| G40.21 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable |
| G40.219 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, without status epilepticus |
| G40.219 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, without status epilepticus |
| G40.81 | Lennox-gastaut syndrome |
| G40.812 | Lennox-gastaut syndrome, not intractable, without status epilepticus |
| G40.814 | Lennox-gastaut syndrome, intractable, without status epilepticus |
Formulary Reference Tool